Simon Völkl

5.5k total citations · 1 hit paper
58 papers, 1.0k citations indexed

About

Simon Völkl is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Simon Völkl has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 30 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Simon Völkl's work include CAR-T cell therapy research (24 papers), Immune Cell Function and Interaction (23 papers) and T-cell and B-cell Immunology (8 papers). Simon Völkl is often cited by papers focused on CAR-T cell therapy research (24 papers), Immune Cell Function and Interaction (23 papers) and T-cell and B-cell Immunology (8 papers). Simon Völkl collaborates with scholars based in Germany, Switzerland and Italy. Simon Völkl's co-authors include Andréas Mackensen, Dimitrios Mougiakakos, Michael Aigner, Regina Jitschin, Georg Schett, Heiko Bruns, Fabian Müller, Martin Böttcher, Andrej Stoll and Domenica Saul and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Simon Völkl

56 papers receiving 1.0k citations

Hit Papers

BCMA CAR T cells in a patient with relapsing idiopathic i... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells
    2025 15 citations Fabian Müller, Simon Völkl et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Völkl Germany 23 461 392 340 144 111 58 1.0k
Leo D. Wang United States 13 330 0.7× 396 1.0× 336 1.0× 170 1.2× 139 1.3× 25 924
Karin Schilbach Germany 21 621 1.3× 517 1.3× 274 0.8× 253 1.8× 50 0.5× 45 1.1k
Kristin L.M. Boylan United States 17 329 0.7× 416 1.1× 375 1.1× 188 1.3× 69 0.6× 28 1.0k
Johannes L. Zakrzewski United States 16 540 1.2× 296 0.8× 357 1.1× 326 2.3× 60 0.5× 42 1.1k
Thomas U. Marron United States 17 766 1.7× 520 1.3× 337 1.0× 53 0.4× 83 0.7× 87 1.4k
Elizabeth M. Morse United States 11 602 1.3× 525 1.3× 416 1.2× 88 0.6× 51 0.5× 14 1.2k
Peggy A. Bulur United States 13 860 1.9× 544 1.4× 302 0.9× 155 1.1× 42 0.4× 27 1.3k
Jessica Dal Col Italy 20 550 1.2× 554 1.4× 469 1.4× 57 0.4× 74 0.7× 35 1.2k
Francis Mussai United Kingdom 18 591 1.3× 510 1.3× 438 1.3× 296 2.1× 93 0.8× 40 1.4k
Tim Luetkens United States 23 718 1.6× 658 1.7× 469 1.4× 416 2.9× 77 0.7× 57 1.4k

Countries citing papers authored by Simon Völkl

Since Specialization
Citations

This map shows the geographic impact of Simon Völkl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Völkl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Völkl more than expected).

Fields of papers citing papers by Simon Völkl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Völkl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Völkl. The network helps show where Simon Völkl may publish in the future.

Co-authorship network of co-authors of Simon Völkl

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Völkl. A scholar is included among the top collaborators of Simon Völkl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Völkl. Simon Völkl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Völkl, Simon, Julius Emons, Matthias Ruebner, et al.. (2025). Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality. BMC Immunology. 26(1). 21–21. 2 indexed citations
2.
Völkl, Simon, David B. Blumenthal, Frederik Graw, et al.. (2025). 3D Tumor microenvironment interaction reveals AP‐1 complex regulation and contact‐mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia. HemaSphere. 9(8). e70199–e70199. 1 indexed citations
3.
4.
Böttcher, Martin, Andrej Stoll, Simon Völkl, et al.. (2024). Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(6). 628.e1–628.e9. 1 indexed citations
5.
Behzad, Ali R., Bernd Lenz, Katharina Luttenberger, et al.. (2024). TaKeTiNa Music Therapy for Outpatient Treatment of Depression: Study Protocol for a Randomized Clinical Trial. Journal of Clinical Medicine. 13(9). 2494–2494.
6.
Wilhelm, Artur, Luis E. Muñoz, Simon Völkl, et al.. (2024). Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry. Molecular Metabolism. 87. 101981–101981. 4 indexed citations
7.
Reimann, Hannah, Kilian Schober, Johan Verhagen, et al.. (2023). Identification and characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains. Immunobiology. 228(5). 152720–152720. 1 indexed citations
8.
Liang, Chunguang, Romy Loschinski, Andrej Stoll, et al.. (2023). Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT. Blood. 141(13). 1626–1639. 8 indexed citations
9.
Müller, Fabian, Sebastian Boeltz, Simon Völkl, et al.. (2023). OP0141 LONG TERM SAFETY AND EFFICACY OF CAR-T CELL TREATMENT IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - DATA FROM THE FIRST SEVEN PATIENTS. Annals of the Rheumatic Diseases. 82. 93–94. 11 indexed citations
10.
Müller, Fabian, Michael Aigner, Simon Völkl, et al.. (2023). Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy. Molecular Therapy — Methods & Clinical Development. 31. 101104–101104. 28 indexed citations
11.
Karl, Franziska, Romy Loschinski, Andrej Stoll, et al.. (2023). Accumulation of T-cell-suppressive PD-L1high extracellular vesicles is associated with GvHD and might impact GvL efficacy. Journal for ImmunoTherapy of Cancer. 11(3). e006362–e006362. 10 indexed citations
12.
Müller, Fabian, Sebastian Boeltz, Johannes Knitza, et al.. (2023). POS1238 FIRST EVIDENCE FOR EFFICACY OF CAR-T CELL TREATMENT IN REFRACTORY ANTISYNTHETASE SYNDROME. Annals of the Rheumatic Diseases. 82. 957–958. 2 indexed citations
13.
Böttcher, Martin, Simon Völkl, Andréas Mackensen, et al.. (2022). The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome. Scientific Reports. 12(1). 11406–11406. 5 indexed citations
14.
Stoll, Andrej, Heiko Bruns, Maximilian Fuchs, et al.. (2021). CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity. Leukemia. 35(12). 3482–3496. 29 indexed citations
15.
Kremer, Andreas E., Carsten Willam, Simon Völkl, et al.. (2021). Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity. European Journal of Immunology. 51(10). 2478–2484. 4 indexed citations
16.
Böttcher, Martin, Andrej Stoll, Romy Loschinski, et al.. (2020). Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling. Cancer Research. 80(17). 3663–3676. 49 indexed citations
17.
Schaffer, Stefanie, Simon Völkl, Katrin Peter, et al.. (2019). Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA. Molecular Cancer Therapeutics. 19(2). 409–419. 25 indexed citations
18.
Aigner, Michael, Kai Hildner, Dimitrios Mougiakakos, et al.. (2019). Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity. Frontiers in Immunology. 10. 883–883. 30 indexed citations
19.
Jitschin, Regina, Domenica Saul, Martina Braun, et al.. (2018). CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells. Journal for ImmunoTherapy of Cancer. 6(1). 116–116. 72 indexed citations
20.
Ullrich, Evelyn, Michael Aigner, Simon Völkl, et al.. (2009). Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany. Cancer Immunology Immunotherapy. 59(11). 1745–1756. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leo D. Wang Breakdown of academic impact, for papers by Karin Schilbach Breakdown of academic impact, for papers by Kristin L.M. Boylan Breakdown of academic impact, for papers by Johannes L. Zakrzewski Breakdown of academic impact, for papers by Thomas U. Marron Breakdown of academic impact, for papers by Elizabeth M. Morse Breakdown of academic impact, for papers by Peggy A. Bulur Breakdown of academic impact, for papers by Jessica Dal Col Breakdown of academic impact, for papers by Francis Mussai Breakdown of academic impact, for papers by Tim Luetkens
Rankless by CCL
2026